ChiCTR1800015213
结束
/
/
/
2018-03-15
/
/
終末期腎病
運動介入計畫對血液透析病人身體功能相關變項之成效
運動介入計畫對血液透析病人身體功能相關變項之成效
運動介入計畫對血液透析病人身體功能相關變項
随机平行对照
治疗新技术
This was randomized controlled trial. The procedure of randomization was done by using a computer generated random numbers. One of the Ph.D student (Wang) generated the random number sequence and she was not involved in the study.
/
天主教耕莘醫療財團法人耕莘醫院
/
38
/
2012-09-01
2014-12-31
/
(1) age above 20 years old and consented to join the study; (2) receive HD 3 times a week at least 3 months; (3) not miss more than two dialysis sessions in the prior month; (4) Kt/V (dialysis efficacy) ≧1.2 and stable on HD; (5) ambulatory with or without using the assistance device, can walk for at least 50 meters; (6) have arteriovenous grafts or native fistulas; and (7) basic comprehension and communication in Chinese or Taiwanese.；
登录查看(1) active infection or inflammation; (2) autoimmunity disorders; (3) cerebrovascular accidents within prior 6 months; (4) presence of severe muscle weakness or interfering skeletal deformity; (5) history of repeated episodes of hypoglycemia; (6) cardiopulmonary contraindications to resistance exercise such as myocardial infarction within prior 6 months, unstable angina, and uncompensated congestive heart failure; (7) lower limb amputation; and (8) history of prior regular exercise program.；
登录查看血液透析中心
/
Medaverse2024-11-24
小药说药2024-11-24
亚泰制药2024-11-24
BioArtMED2024-11-23
新康界2024-11-23
Rimonci2024-11-23
肝脏时间2024-11-23
精准药物2024-11-23
亚泰制药2024-11-23
昌郁医药2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
